Sun, Apr 20, 2014, 8:38 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, Inc. Message Board

  • kot882001 kot882001 Apr 22, 2013 11:31 PM Flag

    I think we've made intermediate top

    IT looks like that 100+ was intermediate top and until good CC we're going to retrace to somewhere around $85...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Hope you did not actually trade on your insights....maybe something else going on...like BC news?

      • 1 Reply to nidan7500
      • Nidan, I've sold June 120c and if ONXX get there will gladly surrender my shares,- at this point I believe that potential for price appreciation of ONXX is much smaller, than it used to be. Sort of "excitement is gone". Unfortunately, I was not able so far to indentify any "ONXX Junior" candidate (i.e. market value 1B-5B, one product on market and some other waiting for approval. The closest I got was VPHM, but also not exactly) so I'm not in the harry to re-deploy funds. (While I've some very potent candidates like CLDX (very large position), NLNK (small position), PATH (small position) and IMMU, GTXI & TSRX (no position yet), they are all totally different and amount of money I've in ONXX are not suitable for them)
        I also find it very amusing that my post- merely reflect my technical opinion got 2 thumbs down. I'd not like to find my-self right, but it is what it is- ONXX hit $94 5 months ago and retraced. Now it got to 100+ and I expect it to do the same. I'm not selling, because eventually it will get another leg up rise to $110-$115, and these price swings have nothing to do with fundamentals...

 
ONXX
124.700.00(0.00%)Sep 30 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.